We are proud to announce the spin-off of Clee Medical SA, a pioneering neurotechnology company that combines ultra-high-resolution intraoperative imaging with AI-powered navigation for minimally invasive brain surgery. This transformative development highlights the Wyss Center’s commitment to supporting groundbreaking innovations that advance neurosurgical precision and patient care.

Clee Medical’s technology addresses critical challenges in neurosurgical procedures by delivering real-time, ultra-high-resolution imaging to guide surgeons with unmatched precision. Leveraging artificial intelligence and machine learning, the system enables the detection of intricate neuroanatomy and vasculature, ensuring safe and targeted access to delicate areas of the brain. This solution represents a significant leap in the accuracy and efficiency of neurosurgical interventions.

“At the Wyss Center, our mission is to translate groundbreaking research into meaningful clinical advancements,” said Dr. Erwin Böttinger, Director of The Wyss Center. “The launch of Clee Medical exemplifies this mission by harnessing state-of-the-art imaging and AI to redefine neurosurgical precision. This innovation not only holds the promise of improving patient outcomes but also highlights the Wyss Center’s dedication to bridging the gap between scientific discovery and real-world impact.”

The spin-off of Clee Medical demonstrates the power of interdisciplinary collaboration and innovation, paving the way for safer and more effective neurosurgical solutions. Surgeons, researchers, and health-tech professionals are invited to learn more about Clee Medical’s groundbreaking work and its potential to redefine the future of brain surgery.

For more information, visit Clee Medical’s website at www.cleemedical.com